MichaelAlanSchwartzMD

Oncology • Miami Beach, FL

Assistant Clinical Professor of Medicine, University Miami School of Medicine

Join to view full profile

Dr. Schwartz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Schwartz's full profile

Already have an account?

Office
4306 Alton Rd
3rd Floor
Miami Beach, FL 33140
Phone+1 305-535-3337

Fax+1 305-535-3324
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1986 - 1987
Rutgers Robert Wood Johnson Medical SchoolClass of 1986

Certifications & Licensure

FL State Medical License 1973 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACP) American College of Physicians, 1997
Super Doctor SuperDoctors.com

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Active, not recruiting
Phase 2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery Start of enrollment: 2015 Nov 10
Active, not recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Coope...
Bruce J Giantonio, Paul J Catalano, Neal J Meropol, Peter J O'Dwyer, Edith P Mitchell, Steven R Alberts, Michael A Schwartz, Al B Benson 3rd> ;Journal of Clinical Oncology. 2023 Jul 20
Splenic Rupture Secondary to Amyloidosis: A Case Report and Review of the Literature.
Hisham F Bahmad, Samantha Gogola, Lorena Burton, Ferial Alloush, Mike Cusnir, Michael Schwartz, Lydia Howard, Vathany Sriganeshan> ;Hematology Reports. 2023 Jun 6
Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529.
Jordan R Kharofa, Greg Yothers, Lisa A Kachnic, Jaffer Ajani, Joshua E Meyer, Mark E Augspurger, Gordon S Okawara, Madhur K Garg, Tracey E Schefter, Todd A Swanson, De...> ;American Journal of Clinical Oncology. 2022 Dec 1
1 citations
Repurposed Effect ofLu-DOTATATE in the Treatment of Mantle Cell Lymphoma.
Lorena P Burton, Hisham F Bahmad, Gerard Chaaya, Michael Schwartz, Elajami, M.> ;Current Oncology. 2022 Oct 9
1 citations
The mutational landscape of upper gastrointestinal adenocarcinomas- A study of similarities and differences.
Kritika Krishnamurthy, Sophia Navajas Urioste, Mike Cusnir, Michael Schwartz, Sarah Alghamdi, Vathany Sriganeshan, Robert Poppiti> ;Pathology, Research and Practice. 2022 Apr 1
ROS1 altered breast cancers - a distinctive molecular subtype of PR- metastatic breast cancers: Expanding the scope of targeted therapeutics.
Kritika Krishnamurthy, Arunima Deb, Sarah Alghamdi, Michael Schwartz, Mike Cusnir, Vathany Sriganeshan, Robert Poppiti> ;Breast Disease. 2022 Jan 1
2 citations
Multiple myeloma presenting as acute tubulointerstitial nephritis.
Ying Long, Abed Alhalim Aljamal, Hisham F. Bahmad, Niharika Yedla, Guillermo A. Herrera, Michael Schwartz, Ayman Layka> ;Autopsy & Case Reports. 2021 Sep 23
1 citations
Analysis of Genetic Alterations in Cutaneous Malignant Melanomas Unveils Unique Loco-Regional Variations and Novel Predictors of Metastatic Potential.
Kritika Krishnamurthy, Sophia Navajas Urioste, Mike Cusnir, Michael Schwartz, Sarah Alghamdi, Vathany Sriganeshan, Robert J. Poppiti> ;The American Journal of Dermatopathology. 2021 Apr 13
10 citations
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)
Electra D. Paskett, Jennifer Le-Rademacher, Jill M. Oliveri, Heshan Liu, Drew K. Seisler, Jeff A. Sloan, Jane M. Armer, Michelle J. Naughton, Karen Hock, Michael Schwa...> ;Cancer. 2021 Jan 15
9 citations
Health-related quality of life outcomes for the LEAP study—CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients
Michelle J. Naughton, Heshan Liu, Drew K. Seisler, Jennifer Le-Rademacher, Jane M. Armer, Jill M. Oliveri, Jeff A. Sloan, Karen Hock, Michael Schwartz, Gary Unzeitig, ...> ;Cancer. 2021 Jan 15
Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metast...
Kritika Krishnamurthy, Mike Cusnir, Michael Schwartz, Vathany Sriganeshan, Robert J. Poppiti> ;Pathology, Research and Practice. 2020 Sep 1
1 citations
A Rare Case of Light Chain Amyloidosis of the Gastrointestinal Tract
Kathrin Dvir, Gliceida M. Galarza-Fortuna, Anna Willet, Christopher A. Febres-Aldana, Nathaly Cortez, Samuel Rapaka, Andre V Coombs, Robert I. Goldberg, Michael Schwar...> ;Case Reports in Surgery. 2020 Jun 30
3 citations
Reactivation of Epstein–Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab Treatment
Anthony J. Febres-Aldana², Christopher A. Febres-Aldana, Kathrin Dvir, Gliceida M. Galarza-Fortuna, Michael Schwartz, Ana Maria Medina, Vathany Sriganeshan> ;Case Reports in Hematology. 2020 Apr 10
1 citations
Title- Genomic landscape of squamous cell carcinoma- Different genetic pathways culminating in a common phenotype
Kritika Krishnamurthy, Allison M Lindsey, Christie-Anne Estrada, Camila C Martinez, Mike Cusnir, Michael Schwartz, Vathany Sriganeshan, Robert J. Poppiti> ;Cancer Treatment and Research Communications. 2020 Jan 1
2 citations
Primary Central Nervous System Lymphoma in an Immunocompetent Patient Presenting as Multiple Cerebellar Lesions: A Case Report and Review of Literature:
Gliceida M Galarza Fortuna, Kathrin Dvir, Christopher A. Febres-Aldana, Michael Schwartz, A. Medina> ;Journal of Investigative Medicine High Impact Case Reports. 2019 Dec 10
1 citations
Delayed Presentation of Thymoma-Related Aplastic Anemia: An Unusual Presentation of a Rare Complication.
Kathrin Dvir, Gliceida M Galarza Fortuna, Michael Schwartz> ;Journal of Hematology. 2019 Oct 28
Join now to see all